Arbutus Biopharma Corp (ABUS) vs Pacific Biosciences of California, Inc. (PACB)
A side-by-side comparison of Arbutus Biopharma Corp and Pacific Biosciences of California, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABUS
Arbutus Biopharma Corp
$4.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PACB
Pacific Biosciences of California, Inc.
$2.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABUS vs PACB
growth of $100 · dividends reinvested · last 10yABUS +38.6% (+3.3%/yr)PACB -68.1% (-10.8%/yr)ABUS compounded faster over this window
ABUS PACB
ABUS vs PACB: by the numbers
- •ABUS is the larger company ($885M vs $839M market cap).
- •ABUS is profitable (84.23% net margin) while PACB runs a net loss (-82.49%).
- •ABUS grew revenue faster over the past five years (85.17% vs 8.52% CAGR).
Metrics side by side
Valuation
| Metric | ABUS | PACB |
|---|---|---|
| P/E ratio | 5.74 | N/A |
| Forward P/E | 6.05 | N/A |
| P/S ratio | 4.87 | 5.27 |
| P/B ratio | 3.42 | N/A |
| EV / EBITDA | 5.90 | N/A |
Profitability
| Metric | ABUS | PACB |
|---|---|---|
| Gross margin | 99.98% | 35.97% |
| Operating margin | -192.08% | -348.46% |
| Net margin | 84.23% | -82.49% |
| ROE | 59.16% | N/A |
| ROIC | 54.39% | -23.80% |
Growth (annualized)
| Metric | ABUS | PACB |
|---|---|---|
| Revenue CAGR (5Y) | 85.17% | 8.52% |
| Total return CAGR (5Y) | 2.19% | -35.20% |
Frequently asked
- Which has grown faster, ABUS or PACB?
- Over the past five years, ABUS grew revenue faster — ABUS at a 85.17% CAGR versus PACB at 8.52%.
- Is ABUS or PACB more profitable?
- ABUS runs the higher net margin — ABUS at 84.23% versus PACB at -82.49%.
- How have ABUS and PACB total returns compared?
- Over the past 10 years, ABUS delivered 2.93% and PACB delivered -10.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arbutus Biopharma P/E ratioArbutus Biopharma ROEPacific Biosciences of California ROEArbutus Biopharma operating marginPacific Biosciences of California operating marginArbutus Biopharma revenue growthPacific Biosciences of California revenue growthArbutus Biopharma free cash flowPacific Biosciences of California free cash flow
Arbutus Biopharma & Pacific Biosciences of California appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.